rs534438354

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PS3PP5

The NM_003896.4(ST3GAL5):​c.1063G>A​(p.Glu355Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV004801587: Functional studies conducted in patient cells, animal models, in vitro and structural modelling demonstrated that this variant impacts protein function (Boccuto et al. 2014)." and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

ST3GAL5
NM_003896.4 missense

Scores

5
11
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:2

Conservation

PhyloP100: 7.79

Publications

6 publications found
Variant links:
Genes affected
ST3GAL5 (HGNC:10872): (ST3 beta-galactoside alpha-2,3-sialyltransferase 5) Ganglioside GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, maintenance of fibroblast morphology, signal transduction, and integrin-mediated cell adhesion. The protein encoded by this gene is a type II membrane protein which catalyzes the formation of GM3 using lactosylceramide as the substrate. The encoded protein is a member of glycosyltransferase family 29 and may be localized to the Golgi apparatus. Mutation in this gene has been associated with Amish infantile epilepsy syndrome. Transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ST3GAL5 Gene-Disease associations (from GenCC):
  • GM3 synthase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV004801587: Functional studies conducted in patient cells, animal models, in vitro and structural modelling demonstrated that this variant impacts protein function (Boccuto et al. 2014).; SCV005204699: This variant was shown to lack detectable enzymatic activity in vitro and in patient cells (example, Indellicato_2019, Boccuto_2014). PMID: 24026681, 34906476, 30576498; SCV003840583: Published functional studies demonstrate that the variant results in loss of enzyme function (Indellicato et al., 2019); PMID: 24026681
PP5
Variant 2-85840338-C-T is Pathogenic according to our data. Variant chr2-85840338-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 140575.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003896.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ST3GAL5
NM_003896.4
MANE Select
c.1063G>Ap.Glu355Lys
missense
Exon 7 of 7NP_003887.3
ST3GAL5
NM_001042437.2
c.994G>Ap.Glu332Lys
missense
Exon 7 of 7NP_001035902.1Q9UNP4-3
ST3GAL5
NM_001354227.2
c.979G>Ap.Glu327Lys
missense
Exon 8 of 8NP_001341156.1A0A0S2Z4S6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ST3GAL5
ENST00000638572.2
TSL:1 MANE Select
c.1063G>Ap.Glu355Lys
missense
Exon 7 of 7ENSP00000491316.1Q9UNP4-1
ST3GAL5
ENST00000393808.8
TSL:1
c.994G>Ap.Glu332Lys
missense
Exon 7 of 7ENSP00000377397.3Q9UNP4-3
ST3GAL5
ENST00000393805.6
TSL:1
c.979G>Ap.Glu327Lys
missense
Exon 7 of 7ENSP00000377394.1Q9UNP4-2

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152194
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000199
AC:
5
AN:
251394
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000109
AC:
16
AN:
1461750
Hom.:
0
Cov.:
31
AF XY:
0.0000110
AC XY:
8
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111878
Other (OTH)
AF:
0.00
AC:
0
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152312
Hom.:
0
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41568
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000216
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.0000330
AC:
4

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
2
-
GM3 synthase deficiency (5)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Uncertain
0.044
T
BayesDel_noAF
Uncertain
0.13
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.48
T
Eigen
Pathogenic
0.87
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.038
D
MetaRNN
Uncertain
0.74
D
MetaSVM
Benign
-0.80
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
7.8
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-3.2
D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.021
D
Polyphen
1.0
D
Vest4
0.93
MutPred
0.77
Gain of ubiquitination at E355 (P = 0.0428)
MVP
0.18
MPC
1.1
ClinPred
0.88
D
GERP RS
5.8
Varity_R
0.80
gMVP
0.81
Mutation Taster
=13/87
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs534438354; hg19: chr2-86067461; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.